Cspc Pharmaceutical | 1093 - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 952K 60K 2026-06
Avita Medical AUD 28.56M 534K 2026-06
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
IQVIA Holdings USD 3.82B 2.05B 2026-09
Jiangsu Hengrui CNY 6.01B 449.22M 2026-09
Kangmei Pharma CNY 1.22B 130.32M 2026-06
Moderna USD 960M 817M 2026-06
Organon & Co USD 1.19B 187M 2026-09
Revvity USD 603.55M 24.8M 2026-06
Sh Fosun Pharma CNY 9.09B 637.86M 2026-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 24.22M 3.08M 2026-06
Viatris USD 3.68B 145.9M 2026-06
Wuxi Apptec CNY 9.07B 580.89M 2026-09
Xeris Pharmaceuticals USD 86.93M 11.72M 2026-06
Zz Pientze Pharmaceu CNY 1.54B 90.74M 2026-09